calcirtiol effect in contrast induced nephropathy

Study of effect of calcitriol in preventing contrast induced nephropathy among patients with kidney dysfunction undergoing coronary angiography or interventions

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20160412027346N7

Enrollment

236

Registered

2019-05-13

Start date

2016-06-21

Completion date

Unknown

Last updated

2019-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

effect of calcitriol in preventing contrast induced nephropathy in patients with renal function undergoing coronary angiography or intervention..

Interventions

Intervention 1: Intervention group: Adults above 18 years old referring to educational hospital for PCI with Scr = 1.3 mg/dl or GFR = 60ml/min were enrolled in study . patients receive 3 calcitriol t

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Adults above 18 years old referring to Taleghani hospital for PCI with Scr = 1.3 mg/dl or GFR = 60ml/min

Exclusion criteria

Exclusion criteria: Active metabolic bone dis, Allergy to vitamin D, vitamin supplementation through 7 days ago, dialysis ,severe hepatic disease.

Design outcomes

Primary

Measure	Time frame
Serum level of cystatin C and its changes. Timepoint: at the beginning of angiography and 24 hours later. Method of measurement: using lab kit with considering elisa method, serum concentration of cystatin c was measured.	—

Secondary

Measure	Time frame
Serum level of creatinine. Timepoint: at baseline and 24 h after intervention. Method of measurement: using lab kit with turbidimetry method.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactshadi ziaie

Shahid Beheshti University of Medical Sciences

s_hassani_85@yahoo.com+98 21 8887 3704

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026